Patent details

Basic Information

Publication number:

92667

Type:

SPC

SPC Type:

Medical

Basic Patent Number:

EP098133606

Legal Status:

Inactive

Application number:

92667

First applicant's nationality:

Procedural language:

French

Marketing Authorization

Marketing Authorization Number:

EU/1/14/982 - Viekirax -ombitasvir/paritaprévir/

Marketing Authorization Type:

Marketing Authorization Date:

19/01/2015

Marketing Authorization Status:

Accepted

Marketing Authorization Country:

Dates

Filing date:

25/02/2015

First Marketing Authorization date:

19/01/2015

Grant date:

24/11/2015

Activation date:

Publication date:

24/11/2015

Lapsed date:

Expiration date:

Renunciation date:

Revocation date:

Annulment date:

Basic SPC Expiration:

19/01/2030

SPC Extension Expiration:

19/01/2030

Rejection date:

Withdrawal date:

Owner

From:

26/03/2024

 

 

Name:

ABBVIE MANUFACTURING MANAGEMENT UNLIMITED COMPANY

Address:

70 Sir John Rogerson’s Quay, Dublin 2, Ireland (IE)

From:

25/02/2015

 

 

Name:

Enanta Pharmaceuticals Inc.

Address:

500 Arsenal Street, Watertown, MA 02472, United States (US)

History of Owners

From:

26/03/2024

To:

26/03/2024

Name:

ABBVIE IRELAND UNLIMITED COMPANY

Address:

70 Sir John Rogerson’s Quay, Dublin 2, Ireland (IE)

From:

25/02/2015

To:

26/03/2024

Name:

AbbVie Bahamas Ltd.

Address:

Sassoon House, Shirley Street & Victoria Avenue, New Providence, Nassau, Bahamas (BS)

Agent

Name:

OFFICE FREYLINGER S.A.

From:

25/02/2015

Address:

Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)

To:

Inventor

1

Name:

CHEN Hui-ju

Address:

United States (US)

2

Name:

LIU Dong

Address:

United States (US)

3

Name:

SUN Ying

Address:

United States (US)

4

Name:

GAI Yonghua

Address:

United States (US)

5

Name:

GRIEME Tim

Address:

United States (US)

6

Name:

OR Yat, Sun

Address:

United States (US)

7

Name:

KU Yiyin

Address:

United States (US)

8

Name:

GRAMPOVNIK David, J.

Address:

United States (US)

9

Name:

MCDANIEL Keith, F.

Address:

United States (US)

10

Name:

WAGAW Sable, H.

Address:

United States (US)

11

Name:

MEI Jianzhang

Address:

United States (US)

12

Name:

SHANLEY Jason, P.

Address:

United States (US)

13

Name:

ENGSTROM Ken

Address:

United States (US)

14

Name:

SHEIKH Ahmad

Address:

United States (US)

15

Name:

KEMPF Dale, J.

Address:

United States (US)

Publication

Bulletin

1

Bulletin Heading:

CO

Bulletin edition number:

2024/05

Publication date:

03/04/2024

Description:

Section M : Transfers of property (Art. 53 of the law), change of name and/or address

2

Bulletin Heading:

CO

Bulletin edition number:

2024/05

Publication date:

03/04/2024

Description:

Section M : Transfers of property (Art. 53 of the law), change of name and/or address

Deed

Change of owner(s)

Change Kind/ Decision Type:

Change of ownership

Deed Number:

RC20240000151A

Date Registered:

26/03/2024

Licence Effective Date:

Licence Expiration Date:

Scope of Licence:

Deed Filer:

OFFICE FREYLINGER S.A.

Journal Edition Number:

Text:

Country Code:

Updated Licence Number:

Terminated Licence Number:

Added Owner(s)

1

Name:

Enanta Pharmaceuticals Inc.

Address:

500 Arsenal Street, Watertown, MA 02472, United States (US)

2

Name:

ABBVIE MANUFACTURING MANAGEMENT UNLIMITED COMPANY

Address:

70 Sir John Rogerson’s Quay, Dublin 2, Ireland (IE)

Removed Pledgee

Name:

Address:

Change of owner(s)

Change Kind/ Decision Type:

Change of ownership

Deed Number:

RC20240000150A

Date Registered:

26/03/2024

Licence Effective Date:

Licence Expiration Date:

Scope of Licence:

Deed Filer:

OFFICE FREYLINGER S.A.

Journal Edition Number:

Text:

Country Code:

Updated Licence Number:

Terminated Licence Number:

Added Owner(s)

1

Name:

Enanta Pharmaceuticals Inc.

Address:

500 Arsenal Street, Watertown, MA 02472, United States (US)

2

Name:

ABBVIE IRELAND UNLIMITED COMPANY

Address:

70 Sir John Rogerson’s Quay, Dublin 2, Ireland (IE)

Removed Pledgee

Name:

Address:

Annual Fees

Annual Fee Due Date:

30/09/2029

Annual Fee Number:

21

Annual Fee Amount:

410 Euro

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages
26/03/2024	Request For Change	19
28/03/2024	Outgoing Correspondence	1
26/03/2024	Request For Change	16
28/03/2024	Outgoing Correspondence	1